Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTXV4FI)

• DTT Name: Albendazole monooxygenase (CYP3A4) DTT Info
• Gene Name: CYP3A4

Molecule-Related Drug & Molecule List

2 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Curcumin	DMQPH29	Solid tumour/cancer	2A00-2F9Z	Phase 3	[1]
PMX-53	DMZUAJ4	Atopic dermatitis	EA80	Phase 2	[2]

64 Investigative Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
(-)-clusin	DMPGJE6	Discovery agent	N.A.	Investigative	[3]
(-)-cubebin	DM57LVW	Discovery agent	N.A.	Investigative	[3]
(-)-cubebinin	DMSTZF9	Discovery agent	N.A.	Investigative	[3]
(-)-cubebininolide	DM8Q6I0	Discovery agent	N.A.	Investigative	[3]
(-)-dihydroclusin	DMNYH3X	Discovery agent	N.A.	Investigative	[3]
(-)-thujaplicatintrimethyl ether	DMKWIYP	Discovery agent	N.A.	Investigative	[3]
(-)-yatein	DMDHGIR	Discovery agent	N.A.	Investigative	[3]
(5-pyridin-3-yl-furan-2-yl)methanethiol	DMKC2BE	Discovery agent	N.A.	Investigative	[4]
(8R,8'R)-4-hydroxycubebinone	DM1UGQN	Discovery agent	N.A.	Investigative	[3]
(8R,8'R,9'S)-5-methoxyclusin	DMVIHTF	Discovery agent	N.A.	Investigative	[3]
1,1':4',1''-terphenyl-3,3''-diol	DMGHAC7	Discovery agent	N.A.	Investigative	[5]
1,2-Diacetoxylycorine	DMBAX2L	Discovery agent	N.A.	Investigative	[6]
1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)	DMYZ548	Discovery agent	N.A.	Investigative	[7]
1-(4-Butoxy-phenyl)-1H-imidazole	DMOEGZV	Discovery agent	N.A.	Investigative	[8]
1-(METHOXYMETHYL)-6-(NAPHTHALEN-2-YL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)	DMI479T	Discovery agent	N.A.	Investigative	[7]
1-Acetoxy-2-tert-butyldimethylsilyl-oxylycorine	DM7DL03	Discovery agent	N.A.	Investigative	[6]
1-Acetoxylycorine	DMQH1MS	Discovery agent	N.A.	Investigative	[6]
1H-1,2,3-benzotriazol-1-amine	DM9KAI5	Discovery agent	N.A.	Investigative	[9]
2,5-bis(4-hydroxybenzylidene)cyclopentanone	DMOQPHK	Discovery agent	N.A.	Investigative	[1]
2-(2-(4-tert-Butylphenylthio)ethyl)-1H-imidazole	DMZVBPG	Discovery agent	N.A.	Investigative	[10]
2-(4-Imidazol-1-yl-phenoxymethyl)-pyridine	DMUIVS9	Discovery agent	N.A.	Investigative	[8]
2-Fluoro-4-[5-(3-hydroxyphenyl)-2-thienyl]phenol	DMUGAT8	Discovery agent	N.A.	Investigative	[11]
2-fluoro-5-(3-methylthiophen-2-yl)pyridine	DMCGI1S	Discovery agent	N.A.	Investigative	[4]
2-tert-Butyldimethylsilyloxylycorine	DMFAV5R	Discovery agent	N.A.	Investigative	[6]
2-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine	DM8A3NI	Discovery agent	N.A.	Investigative	[8]
3,3-(1,3-Thiazole-2,5-diyl)diphenol	DMQY50A	Discovery agent	N.A.	Investigative	[5]
3-(3-methylthiophen-2-yl)pyridine	DMHU9V5	Discovery agent	N.A.	Investigative	[4]
3-(5-((methylthio)methyl)furan-2-yl)pyridine	DM6S28U	Discovery agent	N.A.	Investigative	[4]
3-(5-[1,3]dithiolan-2-yl-furan-2-yl)pyridine	DMOUNPH	Discovery agent	N.A.	Investigative	[4]
3-(pyridin-3-yl)prop-2-yn-1-amine	DM3EDQ1	Discovery agent	N.A.	Investigative	[4]
3-methoxy-5-(6-methoxynaphthalen-2-yl)pyridine	DMF2IW8	Discovery agent	N.A.	Investigative	[12]
3-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine	DMTLJMF	Discovery agent	N.A.	Investigative	[8]
3-[3-(4-Methoxybenzyl)naphthalen-2-yl]pyridine	DM8NRJQ	Discovery agent	N.A.	Investigative	[13]
3-[5-(4-Hydroxyphenyl)-3-thienyl]phenol	DM40GJ8	Discovery agent	N.A.	Investigative	[5]
4-(6-Methoxynaphthalen-2-yl)isoquinoline	DM51XDA	Discovery agent	N.A.	Investigative	[12]
4-[2-(4-Imidazol-1-yl-phenoxy)-ethyl]-morpholine	DM9UGO0	Discovery agent	N.A.	Investigative	[8]
4-[3-(4-Imidazol-1-yl-phenoxy)-propyl]-pyridine	DM7LV5A	Discovery agent	N.A.	Investigative	[8]
4-[5-(3-Hydroxyphenyl)-2-thienyl)-2-methyl]phenol	DMK4ICB	Discovery agent	N.A.	Investigative	[11]
4-[5-(3-Hydroxyphenyl)-3-thienyl]-2-methylphenol	DM7ERYJ	Discovery agent	N.A.	Investigative	[11]
5-(2-phenethylpiperazin-1-yl)-1H-indazole	DM07P5E	Discovery agent	N.A.	Investigative	[14]
5-Pyridin-3-yl-thiophene-2-carbaldehyde oxime	DMZQPTU	Discovery agent	N.A.	Investigative	[15]
6-(3,4-DICHLOROPHENYL)-1-[1-(METHYLOXY)-3-BUTEN-1-YL]-3-AZABICYCLO[4.1.0]HEPTANE (DIASTEREOMERIC MIX)	DMZHFWX	Discovery agent	N.A.	Investigative	[7]
6-(3-Hydroxy-phenyl)-naphthalen-2-ol	DMH8WA2	Discovery agent	N.A.	Investigative	[16]
6-Pyridin-3-yl-3,4-dihydronaphthalen-2(1H)-one	DMIM5DL	Discovery agent	N.A.	Investigative	[17]
Alpha-Hydroxy-Midazolam	DMAQBKX	Discovery agent	N.A.	Investigative	[18]
Alpha-methylcubebin	DM0C4GP	Discovery agent	N.A.	Investigative	[3]
BERGAPTOL	DMDITNB	Discovery agent	N.A.	Investigative	[19]
BMS-536924	DMXJB4N	Discovery agent	N.A.	Investigative	[20]
DIETHOXYFLOURESCEIN	DMK7QXA	Discovery agent	N.A.	Investigative	[21]
DIHYDROCUBEBIN	DMZL7R6	Discovery agent	N.A.	Investigative	[3]
ETHOXYCLUSIN	DM1MGTX	Discovery agent	N.A.	Investigative	[3]
Geranylcoumarin	DMRPWGL	Discovery agent	N.A.	Investigative	[19]
Go-Y026	DMUNSLJ	Discovery agent	N.A.	Investigative	[1]
GSK-8062	DMGW42V	Discovery agent	N.A.	Investigative	[22]
Heme	DMGC287	Discovery agent	N.A.	Investigative	[23]
HINOKININ	DMD6NZO	Discovery agent	N.A.	Investigative	[3]
JATRORRHIZINE	DMYFNW9	Discovery agent	N.A.	Investigative	[24]
MEDIORESINOL	DMDJ6RE	Discovery agent	N.A.	Investigative	[3]
Methyl-(5-pyridin-3-yl-thiophen-2-yl)-amine	DMQU9VD	Discovery agent	N.A.	Investigative	[15]
ML-3163	DM3S5UC	Discovery agent	N.A.	Investigative	[25]
ML-3375	DMXJY6W	Discovery agent	N.A.	Investigative	[25]
ML-3403	DMTQWI8	Discovery agent	N.A.	Investigative	[25]
PALMATINE	DMJCOKV	Discovery agent	N.A.	Investigative	[24]
TILIROSIDE	DMLNTB5	Discovery agent	N.A.	Investigative	[26]

References

• [1] Structure-activity relationships for the inhibition of recombinant human cytochromes P450 by curcumin analogues. Eur J Med Chem. 2008 Aug;43(8):1621-31.
• [2] Peptidomimetic C5a receptor antagonists with hydrophobic substitutions at the C-terminus: increased receptor specificity and in vivo activity. Bioorg Med Chem Lett. 2006 Oct 1;16(19):5088-92.
• [3] Potent CYP3A4 inhibitory constituents of Piper cubeba. J Nat Prod. 2005 Jan;68(1):64-8.
• [4] Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization. J Med Chem. 2006 Nov 30;49(24):6987-7001.
• [5] Design, synthesis, biological evaluation and pharmacokinetics of bis(hydroxyphenyl) substituted azoles, thiophenes, benzenes, and aza-benzenes as p... J Med Chem. 2008 Nov 13;51(21):6725-39.
• [6] Selective cytochrome P450 3A4 inhibitory activity of Amaryllidaceae alkaloids. Bioorg Med Chem Lett. 2009 Jun 15;19(12):3233-7.
• [7] 6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: a new potent and selective triple reuptake inhibitor. J Med Chem. 2010 Jul 8;53(13):4989-5001.
• [8] Imidazole derivatives as new potent and selective 20-HETE synthase inhibitors. Bioorg Med Chem Lett. 2004 Jan 19;14(2):333-6.
• [9] Discovery of a N'-hydroxyphenylformamidine derivative HET0016 as a potent and selective 20-HETE synthase inhibitor. Bioorg Med Chem Lett. 2001 Dec 3;11(23):2993-5.
• [10] Role of hydrophobic substituents on the terminal nitrogen of histamine in receptor binding and agonist activity: development of an orally active hi... J Med Chem. 2010 May 13;53(9):3840-4.
• [11] New insights into the SAR and binding modes of bis(hydroxyphenyl)thiophenes and -benzenes: influence of additional substituents on 17beta-hydroxyst... J Med Chem. 2009 Nov 12;52(21):6724-43.
• [12] Overcoming undesirable CYP1A2 inhibition of pyridylnaphthalene-type aldosterone synthase inhibitors: influence of heteroaryl derivatization on pote... J Med Chem. 2008 Aug 28;51(16):5064-74.
• [13] Novel aldosterone synthase inhibitors with extended carbocyclic skeleton by a combined ligand-based and structure-based drug design approach. J Med Chem. 2008 Oct 9;51(19):6138-49.
• [14] 2-Substituted N-aryl piperazines as novel triple reuptake inhibitors for the treatment of depression, Bioorg. Med. Chem. Lett. 20(13):3941-3945 (2010).
• [15] 5-substituted, 6-substituted, and unsubstituted 3-heteroaromatic pyridine analogues of nicotine as selective inhibitors of cytochrome P-450 2A6. J Med Chem. 2005 Jan 13;48(1):224-39.
• [16] Design, synthesis, and biological evaluation of (hydroxyphenyl)naphthalene and -quinoline derivatives: potent and selective nonsteroidal inhibitors... J Med Chem. 2008 Apr 10;51(7):2158-69.
• [17] In vivo active aldosterone synthase inhibitors with improved selectivity: lead optimization providing a series of pyridine substituted 3,4-dihydro-... J Med Chem. 2008 Dec 25;51(24):8077-87.
• [18] Design and synthesis of a new fluorescent probe for cytochrome P450 3A4 (CYP 3A4). Bioorg Med Chem Lett. 2003 Nov 3;13(21):3643-5.
• [19] Radical scavenging and cytochrome P450 3A4 inhibitory activity of bergaptol and geranylcoumarin from grapefruit. Bioorg Med Chem. 2007 Jun 1;15(11):3684-91.
• [20] Discovery and evaluation of 4-(2-(4-chloro-1H-pyrazol-1-yl)ethylamino)-3-(6-(1-(3-fluoropropyl)piperidin-4-yl)-4-methyl-1H-benzo[d]imidazol-2-yl)py... J Med Chem. 2008 Oct 9;51(19):5897-900.
• [21] Exploration of the amine terminus in a novel series of 1,2,4-triazolo-3-yl-azabicyclo[3.1.0]hexanes as selective dopamine D3 receptor antagonists. J Med Chem. 2010 Oct 14;53(19):7129-39.
• [22] Conformationally constrained farnesoid X receptor (FXR) agonists: Naphthoic acid-based analogs of GW 4064. Bioorg Med Chem Lett. 2008 Aug 1;18(15):4339-43.
• [23] The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
• [24] Cytochrome P3A4 inhibitors and other constituents of Fibraurea tinctoria. J Nat Prod. 2007 Dec;70(12):1930-3.
• [25] Novel substituted pyridinyl imidazoles as potent anticytokine agents with low activity against hepatic cytochrome P450 enzymes. J Med Chem. 2003 Jul 17;46(15):3230-44.
• [26] Isolation of cytochrome P450 inhibitors from strawberry fruit, Fragaria ananassa. J Nat Prod. 2004 Nov;67(11):1839-41.